79
64
Growth Score 79 in past quarter
-11 pts
Heat Score 64 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
698678
Cypress Bioscience provides therapeutics and personalized medicine services to facilitate improved and individualized patient care.
Sabrina Martucci Johnson: Executive Vice President, Chief Operating Officer and Chief Financial Officer
Jay D. Kranzler: Chief Executive Officer and Chairman
About the Company
Cypress Bioscience is a medical service provider that facilitates individualized patient care.
The service provides its patients with therapeutic and personalized medical services in a variety of needs such as isolated areas of pain, rheumatology, and physical medicine and rehabilitation. It also addresses challenging disorders such as
fibromyalgia and rheumatoid arthritis. Furthermore, the organization engages in the development of drugs such as Savella, a milnacipran HCI for the treatment of fibromyalgia, as well as Prosorba, a medical device for rheumatoid arthritis.
Cypress Bioscience was founded in 1981 and is based in San Diego, California.